Richtech Robotics (NASDAQ:RR), a company that specializes in developing, manufacturing, and deploying robotic solutions for ...

BROADEN2 Phase 2b trial in atopic dermatitis (AD) ongoing, with data expected by mid-2027KT-621 BREADTH Phase 2b trial in asthma ...

This afternoon, we released financial results for the quarter and full year ended December 31, 2025, and recent corporate updates. The press release is available on the Investors section of our ...

The military-industrial complex is flourishing under Trump, but that doesn’t mean we can’t be optimistic about the nation’s ...

And as we lean in further, AI is strengthening our advantage, enabling significantly more automation and value for our customers, embedding our products more deeply into their daily operations and ...

Net product sales -- $521 million for 2025, comprised of $245 million Livmarli U.S., $115 million Livmarli international, and $161 million from bile acid medicines; total exceeded prior guidance range ...

At the invitation of His Excellency Narendra Modi, Prime Minister of India, the Right Honourable Mark Carney, Prime Minister of Canada, paid an official visit to India from February 27 -- March 2, ...

Hello, and welcome to today's conference call to discuss Rocket Lab USA, Inc.'s fourth quarter and full year 2025 financial results, business highlights, and other updates. At the end of Q4, our ...

Modernizing biomanufacturing methods and reducing regulatory burdens are key landmarks on India’s roadmap for expanding biosimilars development.

Senseonics Holdings, Inc. (NASDAQ:SENS) Q4 2025 Earnings Call Transcript March 2, 2026 Senseonics Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.47565 EPS, expectations were ...

Microsoft's Phi-4-reasoning-vision-15B uses careful data curation and selective reasoning to compete with models trained on ...